![Fabienne Steens](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fabienne Steens
Directeur en chef des Investissements chez Biomedical Diagnostics NV
Postes actifs de Fabienne Steens
Sociétés | Poste | Début | Fin |
---|---|---|---|
Biomedical Diagnostics NV
![]() Biomedical Diagnostics NV Medical DistributorsDistribution Services Part of Eurobio-Scientific SA, Biomedical Diagnostics NV was founded in 2003 and is a Belgian company that provides high-quality reagents and reliable instruments for in vitro diagnostics in the Benelux. The company is based in Antwerp, Belgium. Biomedical Diagnostics offers collection and preservation products that protect sample integrity during transportation and storage, ensuring preanalytical variables are controlled and the samples are protected. The company's products include blood collection tubes, cell-free DNA BCT, RNA complete BCT, and Cyto-Chex BCT. Additionally, Biomedical Diagnostics offers stabilization reagents such as Streck cell preservative and Streck cell-free DNA urine preserve. On June 13, 2022, Biomedical Diagnostics was acquired by Eurobio-Scientific SA. | Directeur/Membre du Conseil | 28/01/2003 | - |
Directeur en chef des Investissements | 28/01/2003 | - |
Historique de carrière de Fabienne Steens
Statistiques
Internationale
Belgique | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Investment Officer | 1 |
Sectorielle
Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Biomedical Diagnostics NV
![]() Biomedical Diagnostics NV Medical DistributorsDistribution Services Part of Eurobio-Scientific SA, Biomedical Diagnostics NV was founded in 2003 and is a Belgian company that provides high-quality reagents and reliable instruments for in vitro diagnostics in the Benelux. The company is based in Antwerp, Belgium. Biomedical Diagnostics offers collection and preservation products that protect sample integrity during transportation and storage, ensuring preanalytical variables are controlled and the samples are protected. The company's products include blood collection tubes, cell-free DNA BCT, RNA complete BCT, and Cyto-Chex BCT. Additionally, Biomedical Diagnostics offers stabilization reagents such as Streck cell preservative and Streck cell-free DNA urine preserve. On June 13, 2022, Biomedical Diagnostics was acquired by Eurobio-Scientific SA. | Distribution Services |
- Bourse
- Insiders
- Fabienne Steens
- Expérience